TPI Fund Managers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$7.08M Sell
78,870
-821
-1% -$83.2K 1.19% 30
2022
Q1
$8.84M Buy
79,691
+3,822
+5% +$404K 1.14% 34
2021
Q4
$7.85M Sell
75,869
-106,517
-58% -$12.3M 0.97% 35
2021
Q3
$22.9M Buy
182,386
+1,107
+0.6% +$143K 3.09% 14
2021
Q2
$22.5M Sell
181,279
-6,686
-4% -$839K 3.1% 10
2021
Q1
$22.2M Sell
187,965
-45,088
-19% -$5.28M 3.47% 11
2020
Q4
$27.3M Buy
233,053
+12,794
+6% +$1.41M 4.67% 5
2020
Q3
$22.9M Buy
220,259
+1,806
+0.8% +$181K 4.88% 5
2020
Q2
$20M Buy
218,453
+11,556
+6% +$1.11M 4.65% 6
2020
Q1
$18.7M Sell
206,897
-9,695
-4% -$1.03M 5.66% 4
2019
Q4
$24.6M Buy
216,592
+17,820
+9% +$1.96M 5.91% 3
2019
Q3
$21.6M Buy
198,772
+8,932
+5% +$932K 6.14% 2
2019
Q2
$18.5M Buy
+189,840
New +$17.3M 5.65% 3

Other funds holding MDT

TPI Fund Managers's MDT Position: Q2 2022 in Review

TPI Fund Managers reduced its Medtronic (MDT) stake by 1% in Q2 2022, selling an estimated $83.2K and leaving 78,870 shares worth $7.08M. The position accounts for 1.19% of the portfolio, ranked #30.

TPI Fund Managers first reported a position in MDT in Q2 2019 and has held it in 13 quarters since. The position peaked at $27.3M in Q4 2020. 2,021 funds tracked by Wall St. Rank hold MDT as of Q2 2022.

  • TPI Fund Managers held 78,870 shares of Medtronic worth $7.08M as of Q2 2022.
  • TPI Fund Managers sold 821 Medtronic shares in Q2 2022, an estimated $83.2K.
  • Medtronic made up 1.19% of TPI Fund Managers's portfolio in Q2 2022, its #30 holding.
  • TPI Fund Managers first reported a position in Medtronic in Q2 2019 and has held it in 13 quarters since.
  • TPI Fund Managers's Medtronic position peaked at $27.3M in Q4 2020.
  • 2,021 funds tracked by Wall St. Rank held Medtronic as of Q2 2022.

Based on TPI Fund Managers's 13F filing for Q2 2022, filed 8 Aug 2022.